Literature DB >> 1906829

Abnormal permeability precedes the development of a gluten sensitive enteropathy in Irish setter dogs.

E J Hall1, R M Batt.   

Abstract

Intestinal permeability to 51Cr-EDTA was examined during the development of gluten sensitive enteropathy in dogs bred from affected Irish setters and reared on a normal wheat containing diet. Comparisons were made with litter mates reared on a gluten free diet and with a control group of age matched, clinically healthy Irish setters reared on the normal diet. Studies at 4, 6, 8, and 12 months of age were correlated with morphometric and biochemical examinations of peroral jejunal biopsy specimens. Permeability was increased at all ages in the group fed gluten free diet compared with control dogs, although there were no differences in villus height, intraepithelial lymphocyte density, and alkaline phosphatase activity. At four months, permeability in the normal diet group was greater than in controls, although comparable with that in the gluten free diet group. Permeability in the normal diet group increased further in conjunction with the development of partial villus atrophy and reduced alkaline phosphatase activity, and by 12 months permeability was significantly greater than in their gluten free diet litter mates and the control dogs. The findings suggest that an underlying permeability abnormality may be involved in the pathogenesis of gluten sensitive enteropathy in Irish setter dogs.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1906829      PMCID: PMC1378989          DOI: 10.1136/gut.32.7.749

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  37 in total

1.  Abnormal intestinal permeability and jejunal morphometry.

Authors:  L D Juby; M F Dixon; A T Axon
Journal:  J Clin Pathol       Date:  1987-07       Impact factor: 3.411

2.  Intestinal permeability to lactulose/L-rhamnose in children with celiac disease and other gastrointestinal disorders.

Authors:  L Stenhammar; S Strömberg
Journal:  J Pediatr Gastroenterol Nutr       Date:  1988 Mar-Apr       Impact factor: 2.839

3.  Enzymatic digestion of gliadin: the effect of the resultant peptides in adult celiac disease.

Authors:  H D Bronstein; L J Haeffner; O D Kowlessar
Journal:  Clin Chim Acta       Date:  1966-08       Impact factor: 3.786

4.  Comparison between the cellobiose/mannitol and 51Cr-labelled ethylenediaminetetra-acetate absorption tests in the detection of coeliac disease.

Authors:  D Martines; A I Morris; I T Gilmore; A Williams; H Stockdale; M Critchley; G A Smith; D Billington
Journal:  Clin Sci (Lond)       Date:  1988-10       Impact factor: 6.124

5.  Intestinal permeability to inert sugars and different-sized polyethyleneglycols in children with celiac disease.

Authors:  L Stenhammar; K Fälth-Magnusson; G Jansson; K E Magnusson; T Sundqvist
Journal:  J Pediatr Gastroenterol Nutr       Date:  1989-10       Impact factor: 2.839

6.  Radionuclide tests for the assessment of intestinal permeability.

Authors:  R H Behrens; K F Szaz; C Northrop; M Elia; G Neale
Journal:  Eur J Clin Invest       Date:  1987-04       Impact factor: 4.686

7.  Assessment of canine intestinal permeability, using 51Cr-labeled ethylenediaminetetraacetate.

Authors:  E J Hall; R M Batt; A Brown
Journal:  Am J Vet Res       Date:  1989-12       Impact factor: 1.156

8.  Lactulose/mannitol test: an ideal screen for celiac disease.

Authors:  L D Juby; J Rothwell; A T Axon
Journal:  Gastroenterology       Date:  1989-01       Impact factor: 22.682

9.  Cellobiose/mannitol sugar test--a sensitive tubeless test for coeliac disease: results on 1010 unselected patients.

Authors:  L D Juby; J Rothwell; A T Axon
Journal:  Gut       Date:  1989-04       Impact factor: 23.059

10.  Bacterial chemotactic oligopeptides and the intestinal mucosal barrier.

Authors:  D M Ferry; T J Butt; M F Broom; J Hunter; V S Chadwick
Journal:  Gastroenterology       Date:  1989-07       Impact factor: 22.682

View more
  15 in total

1.  Dietary modulation of gluten sensitivity in a naturally occurring enteropathy of Irish setter dogs.

Authors:  E J Hall; R M Batt
Journal:  Gut       Date:  1992-02       Impact factor: 23.059

2.  Association between celiac disease and idiopathic dilated cardiomyopathy: a case report.

Authors:  Elisa Romagnoli; Elena Boldrini; Antonello Pietrangelo
Journal:  Intern Emerg Med       Date:  2010-08-25       Impact factor: 3.397

Review 3.  Alterations in intestinal permeability.

Authors:  M C Arrieta; L Bistritz; J B Meddings
Journal:  Gut       Date:  2006-10       Impact factor: 23.059

Review 4.  Intestinal barrier function: molecular regulation and disease pathogenesis.

Authors:  Katherine R Groschwitz; Simon P Hogan
Journal:  J Allergy Clin Immunol       Date:  2009-07       Impact factor: 10.793

Review 5.  The measurement and clinical significance of intestinal permeability.

Authors:  Christopher W Teshima; Jon B Meddings
Journal:  Curr Gastroenterol Rep       Date:  2008-10

6.  Gluten-sensitive enteropathy in a family of Irish setters.

Authors:  S C Daminet
Journal:  Can Vet J       Date:  1996-12       Impact factor: 1.008

Review 7.  The intestinal epithelial barrier: a therapeutic target?

Authors:  Matthew A Odenwald; Jerrold R Turner
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-11-16       Impact factor: 46.802

8.  Antibodies to the wheat storage globulin Glo-3A in children before and at diagnosis of celiac disease.

Authors:  Craig E Taplin; Majid Mojibian; Melissa Simpson; Iman Taki; Edwin Liu; Edward J Hoffenberg; Jill M Norris; Fraser W Scott; Marian Rewers
Journal:  J Pediatr Gastroenterol Nutr       Date:  2011-01       Impact factor: 2.839

Review 9.  The potential utility of tight junction regulation in celiac disease: focus on larazotide acetate.

Authors:  Shahryar Khaleghi; Josephine M Ju; Abhinav Lamba; Joseph A Murray
Journal:  Therap Adv Gastroenterol       Date:  2016-01       Impact factor: 4.409

10.  Lymphocytic gastritis and associated small bowel disease: a diffuse lymphocytic gastroenteropathy?

Authors:  D A Lynch; G M Sobala; M F Dixon; A Gledhill; P Jackson; J E Crabtree; A T Axon
Journal:  J Clin Pathol       Date:  1995-10       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.